4D Pharma Says MRx0518 Part B Study Enrolment Continues To Progress Read More
4D Pharma Joins Landmark Study For Parkinson's Treatment Development Read More
4D Pharma Files US Registration Statement For ADR Programme Read More
IN BRIEF: 4d Pharma Reports Positive Data From Ongoing MRx051 Trials Read More
IN BRIEF: 4D Pharma Proposes Merger With Longevity Acquisition Read More
UK WINNERS & LOSERS SUMMARY: Shaftesbury Down 13% Amid Fundraise Plans Read More
4D Pharma Reports Positive Results From Bowel Syndrome Treatment Trial Read More
IN BRIEF: 4D Pharma Interim Loss Widens On R&D Costs Increase Read More
UK EXECUTIVE CHANGE SUMMARY: Primorus Adds Three Directors To Board Read More
UK WINNERS & LOSERS SUMMARY: Provident Financial Up On Better Outlook Read More
4D Pharma Says Results In MRx0518, Keytruda Cancer Trial "Encouraging" Read More
UK TRADING UPDATE SUMMARY: Mineral & Financial Invests In Ideon Tech Read More
4D Pharma To Raise GBP7.7 Million In Share Issue, Eyes US Listing Read More
4D Pharma Starts Treatment Of Patients In Phase 2 Of MRx0518 Trial Read More
4d Pharma Starts Covid-19 Patients Enrollment For MRx-4DP0004 Study Read More
4d Pharma Reports Revenue For 2019 But Loss Widens On Higher Costs Read More
4D Pharma Completes First Part Of Clinical Trial For Cancer Treatment Read More
4D Pharma Stock Jumps 60% As Gets Approval For Study Of Covid-19 Drug Read More
4D Pharma Appoints New Chair, Reports Encouraging Blautix Trial Data Read More
DIRECTOR DEALINGS SUMMARY: Wizz Air Chair Buys GBP700,000 In Shares Read More
